がん化学療法レジメンの違いによる制吐療法の評価:―VASを用いた評価―
スポンサーリンク
概要
- 論文の詳細を見る
Chemotherapy-induced nausea and vomiting (CINV) are serious adverse effects, lowering the QOL of patients. The guideline published in 2010 provided information for proper use of antiemetic agents in patients treated with cancer chemotherapy. The risks of CINV were classified into four categories by the emetogenic potency of anti-cancer drugs and the antiemetic therapy was recommended based on the risks of CINV in the guideline. However, it was often the case that antiemetic effects were varied even though patients were treated according to the guideline in multidrug combination regimen. In this study, we tried to quantify the extent of nausea with visual analog scale (VAS) and investigated the effects of antiemetic therapy in patients treated with S1/CDDP and FP regimens, which are both categorized as the same highest risk of CINV in the guideline. As a result, in combination with radiotherapy of the FP regimen,the VAS values tended to be higher in the patients treated with non-radiotherapy of the FP regimen and the S1/CDDP regimen. In addition, the nausea was found to be prolonged in patients treated with the combination with radiotherapy of FP regimen. After the antiemetic therapy was modified according to the guideline, a significant effect of aprepitant on the prolonged nausea was not observed in the multi-drug combination regimen. In conclusion, the antiemetic effects were varied dependently on the regimens, even though those are categorized as the same risk, and VAS could be useful to quantify the nausea induced by cancer chemotherapy.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)